View in EDS

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.

Saved in:
Bibliographic Details
Title: Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
Authors: Bodor JN; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Patel JD; Hematology Oncology Division, Northwestern University, Chicago, IL., Wakelee HA; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA., Levy BP; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC., Borghaei H; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Pellini B; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL., Costello MR; Department of Hematology/Oncology, University of Pennsylvania Abramson Cancer Center at Chester County Hospital, West Chester, PA., Dowell JE; Department of Hematology/Oncology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX., Finley G; Department of Medical Oncology, Allegheny Health Network, Pittsburgh, PA., Huang CH; Department of Medical Oncology, University of Kansas Medical Center, Kansas City, KS., Neal JW; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA., Nieva JJ; Department of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Puri S; Division of Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT., Socinski MA; Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, FL., Thomas C; New England Cancer Specialists, Scarborough, ME., Ross EA; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Litwin S; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Clapper ML; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Treat J; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: joseph.treat2@fccc.edu.
Source: Clinical lung cancer [Clin Lung Cancer] 2023 Nov; Vol. 24 (7), pp. e242-e246. Date of Electronic Publication: 2023 May 11.
Publication Type: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37451930
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bodor+JN%22">Bodor JN</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Patel+JD%22">Patel JD</searchLink>; Hematology Oncology Division, Northwestern University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Wakelee+HA%22">Wakelee HA</searchLink>; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Levy+BP%22">Levy BP</searchLink>; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Borghaei+H%22">Borghaei H</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Pellini+B%22">Pellini B</searchLink>; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL.<br /><searchLink fieldCode="AU" term="%22Costello+MR%22">Costello MR</searchLink>; Department of Hematology/Oncology, University of Pennsylvania Abramson Cancer Center at Chester County Hospital, West Chester, PA.<br /><searchLink fieldCode="AU" term="%22Dowell+JE%22">Dowell JE</searchLink>; Department of Hematology/Oncology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Finley+G%22">Finley G</searchLink>; Department of Medical Oncology, Allegheny Health Network, Pittsburgh, PA.<br /><searchLink fieldCode="AU" term="%22Huang+CH%22">Huang CH</searchLink>; Department of Medical Oncology, University of Kansas Medical Center, Kansas City, KS.<br /><searchLink fieldCode="AU" term="%22Neal+JW%22">Neal JW</searchLink>; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA.<br /><searchLink fieldCode="AU" term="%22Nieva+JJ%22">Nieva JJ</searchLink>; Department of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Puri+S%22">Puri S</searchLink>; Division of Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Socinski+MA%22">Socinski MA</searchLink>; Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, FL.<br /><searchLink fieldCode="AU" term="%22Thomas+C%22">Thomas C</searchLink>; New England Cancer Specialists, Scarborough, ME.<br /><searchLink fieldCode="AU" term="%22Ross+EA%22">Ross EA</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Litwin+S%22">Litwin S</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Clapper+ML%22">Clapper ML</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Treat+J%22">Treat J</searchLink>; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: joseph.treat2@fccc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2023 Nov; Vol. 24 (7), pp. e242-e246. <i>Date of Electronic Publication: </i>2023 May 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37451930
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2023.05.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e242
    Titles:
      – TitleFull: Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bodor JN
      – PersonEntity:
          Name:
            NameFull: Patel JD
      – PersonEntity:
          Name:
            NameFull: Wakelee HA
      – PersonEntity:
          Name:
            NameFull: Levy BP
      – PersonEntity:
          Name:
            NameFull: Borghaei H
      – PersonEntity:
          Name:
            NameFull: Pellini B
      – PersonEntity:
          Name:
            NameFull: Costello MR
      – PersonEntity:
          Name:
            NameFull: Dowell JE
      – PersonEntity:
          Name:
            NameFull: Finley G
      – PersonEntity:
          Name:
            NameFull: Huang CH
      – PersonEntity:
          Name:
            NameFull: Neal JW
      – PersonEntity:
          Name:
            NameFull: Nieva JJ
      – PersonEntity:
          Name:
            NameFull: Puri S
      – PersonEntity:
          Name:
            NameFull: Socinski MA
      – PersonEntity:
          Name:
            NameFull: Thomas C
      – PersonEntity:
          Name:
            NameFull: Ross EA
      – PersonEntity:
          Name:
            NameFull: Litwin S
      – PersonEntity:
          Name:
            NameFull: Clapper ML
      – PersonEntity:
          Name:
            NameFull: Treat J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1